Clinical science
Evolution of cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis: are there treatment alternatives?

https://doi.org/10.1016/j.amjsurg.2010.04.010Get rights and content

References (24)

  • R.L. Dedrick

    Interspecies scaling of regional drug delivery

    J Pharmacol Sci

    (1986)
  • L. Bijelic et al.

    Systematic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancer

    Ann Oncol

    (2007)
  • Chua TC, Liauw W, Saxena A, et al. Evolution of loco-regional treatment for peritoneal carcinomatosis: single-centre...
  • P. Glasziou et al.

    When are randomised trials unnecessary?Picking signal from noise

    BMJ

    (2007)
  • P.H. Sugarbaker

    Epithelial appendiceal neoplasms

    Cancer J

    (2009)
  • D. Elias et al.

    Peritoneal colorectal carcinomatosis treated with surgery and perioperative intraperitoneal chemotherapy: retrospective analysis of 523 patients from a multicentric French study

    J Clin Oncol

    (2010)
  • T.D. Yan et al.

    Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma

    J Clin Oncol

    (2006)
  • D. Baratti et al.

    Lymph node metastases in diffuse malignant peritoneal mesothelioma

    Ann Surg Oncol

    (2010)
  • P.H. Sugarbaker

    Five reasons why cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy must be regarded as the new standard of care for diffuse malignant peritoneal

    Ann Surg Oncol

    (2010)
  • J.S. Spratt et al.

    Clinical delivery system for intraperitoneal hyperthermic chemotherapy

    Cancer Res

    (1980)
  • S. Koga et al.

    Treatment of implanted peritoneal cancer in rats by continuous hyperthermic peritoneal perfusion in combination with an anticancer drug

    Cancer Res

    (1984)
  • F.N. Gilly et al.

    Intra-peritoneal chemo-hyperthermia (CHIP): a new therapy in the treatment of the peritoneal seedingsPreliminary report

    Int Surg

    (1991)
  • Cited by (22)

    • Best practice for perioperative management of patients with cytoreductive surgery and HIPEC

      2017, European Journal of Surgical Oncology
      Citation Excerpt :

      As this procedure is technically challenging with potential high morbidity and mortality up to 12.0–52.0% and 0.9–5.8%, respectively,16 institutional experience is essential for optimal treatment and prevention of adverse events.17 Sugarbaker et al. clearly demonstrated a decrease in 30-day in-hospital morbidity and mortality from 35% to 5% to as low as 19% and 2%, respectively, depending among other things on physician and nursing staff expertise in caring for these patients.8,18 Therefore, centralization of the procedure to specialized institutions is recommended and the German Society for General and Visceral Surgery is certifying centers of competence for surgical treatment of peritoneal malignancies.

    View all citing articles on Scopus
    View full text